Tag: MASLD
-
MASLD: Managing disease progression in metabolic liver disease
Understanding MASLD and MASH Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing health concern tied to obesity, insulin resistance, and metabolic syndrome. In MASLD, fat accumulates in the liver, which can progress to metabolic dysfunction-associated steatohepatitis (MASH) when inflammation and liver cell injury accompany fat deposition. This progression increases the risk of fibrosis, cirrhosis,…
-
Managing Disease Progression in MASLD and MASH: A Practical Guide
Understanding MASLD and MASH Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common liver condition characterized by fat buildup in the liver linked to metabolic risk factors such as obesity, type 2 diabetes, and insulin resistance. When MASLD progresses to a stage with inflammation and hepatocellular injury, it may evolve into metabolic associated steatohepatitis (MASH),…
-
Managing Disease Progression in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Its Inflammatory Form (MASH)
Understanding MASLD and Its Inflammatory Counterpart, MASH Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common condition characterized by fat accumulation in the liver tied to metabolic dysfunction. When fat buildup is accompanied by liver inflammation and injury, the condition is referred to as MASLD-associated steatohepatitis (MASH) or simply MASH. While MASLD can be a…
-
Fatty Liver Cure: Could Pemafibrate and Telmisartan Reversethe Disease?
New Study Suggests a Surprising Duo for Fatty Liver Cure Fatty liver disease, or MASLD/NAFLD as it’s increasingly called, has earned its reputation as a global silent killer. The condition unfolds quietly as excess fat accumulates in liver cells, potentially progressing to inflammation, fibrosis, and even cirrhosis or liver cancer. While lifestyle changes remain the…
-
Fatty Liver Cure: Pemafibrate and Telmisartan Combo May Reverse MASLD
New hope in fatty liver disease: a drug combination that could reverse MASLD Fatty liver disease, now increasingly called MASLD (Metabolic Associated Steatosis with Liver Disease), affects millions worldwide and is rising in prevalence alongside obesity and sedentary lifestyles. While lifestyle changes remain essential, researchers have long searched for therapies that can halt or reverse…
-
Fatty Liver Cure: How Two Common Cardiovascular Drugs Could Reverses Fatty Liver Disease
The Breakthrough: A New Hope for Fatty Liver Disease Fatty liver disease, or MASLD (formerly NAFLD), affects millions worldwide and has long lacked a proven medical cure. A recent study from researchers at the University of Barcelona suggests a provocative approach: combining two widely used cardiovascular drugs—pemafibrate and telmisartan—to actively reduce liver fat and improve…
-
Repurposed antihypertensive and lipid-lowering drugs show promise against MASLD
New hope for MASLD through drug repurposing Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the world’s most common liver disorder, affecting roughly one in three adults. It involves fat buildup in liver cells and is linked to serious liver outcomes and a heightened risk of cardiovascular mortality. A recent study from the University of…
-
Repurposed Antihypertensive and Lipid-Lowering Drugs Show Promise Against MASLD
MASLD: A Global Liver Disease in Need of Safe, Effective Treatments Metabolic dysfunction-associated steatotic liver disease (MASLD) is now recognized as the world’s most common liver disorder, affecting roughly one in three adults. The disease is characterized by fat buildup in liver cells, which can progress to liver dysfunction and is closely linked to higher…
-
Rising MASLD Cases: Exams, AI Roles, and Prevention in Fatty Liver
Understanding the Surge in MASLD Fatty liver disease is increasingly common worldwide, with MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) emerging as the predominant form. Global estimates place the prevalence around 38% among adults, with a notable 15% increase over the last two decades. MASLD often coexists with metabolic disorders such as obesity, type 2 diabetes,…
-
Rising Fatty Liver Cases (+15%): Tests, AI Tools, and MasLD Insights
Rising fatty liver cases: what MasLD means for health Recent expert discussions highlight a worrying rise in fatty liver disease. Known as Metabolic dysfunction-associated steatotic liver disease (MasLD), this condition now affects a large share of adults worldwide and is increasingly recognized as a major public health challenge. MasLD describes the abnormal buildup of fat…